Prior to the March 2018 settlement, Holmes held a 50-percent stock ownership in Theranos. Forbes listed her as one of "America's richest Self-Made Women" in 2015 with a net worth of $4.5 billion. In June 2016, Forbes released an updated valuation of $800 million for Theranos, which made Holmes’s stake essentially worthless, because other Investors owned preferred shares and would have been paid before Holmes, who owned only Common stock. Holmes reportedly owes a $25 million debt to Theranos in connection with exercising options. She did not receive any company cash from the arrangement, nor did she sell any of her shares, including those associated with the debt.